Symbols / SENS
SENS Chart
About
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 336.27M |
| Enterprise Value | 266.48M | Income | -63.77M | Sales | 29.30M |
| Book/sh | 1.92 | Cash/sh | 2.72 | Dividend Yield | — |
| Payout | 0.00% | Employees | 117 | IPO | — |
| P/E | — | Forward P/E | -3.41 | PEG | — |
| P/S | 11.48 | P/B | 4.30 | P/C | — |
| EV/EBITDA | -4.46 | EV/Sales | 9.10 | Quick Ratio | 5.71 |
| Current Ratio | 6.23 | Debt/Eq | 52.66 | LT Debt/Eq | — |
| EPS (ttm) | -1.54 | EPS next Y | -2.41 | EPS Growth | — |
| Revenue Growth | 89.90% | Earnings | 2026-03-02 | ROA | -32.64% |
| ROE | -129.29% | ROIC | — | Gross Margin | 41.11% |
| Oper. Margin | -242.14% | Profit Margin | -217.65% | Shs Outstand | 40.86M |
| Shs Float | 36.97M | Short Float | 10.72% | Short Ratio | 9.00 |
| Short Interest | — | 52W High | 20.96 | 52W Low | 5.25 |
| Beta | 0.94 | Avg Volume | 451.31K | Volume | 250.71K |
| Target Price | $18.92 | Recom | Buy | Prev Close | $8.19 |
| Price | $8.23 | Change | 0.49% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$18.92
Mean price target
2. Current target
$8.45
Latest analyst target
3. DCF / Fair value
$-14.87
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$8.45
Low
$9.00
High
$31.00
Mean
$18.92
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-11-06 | main | HC Wainwright & Co. | Buy → Buy | $19 |
| 2025-11-05 | main | TD Cowen | Buy → Buy | $15 |
| 2025-11-05 | main | Barclays | Overweight → Overweight | $31 |
| 2025-08-27 | init | Barclays | — → Overweight | $2 |
| 2025-07-15 | init | TD Cowen | — → Buy | $1 |
| 2025-07-08 | main | HC Wainwright & Co. | Buy → Buy | $1 |
| 2025-04-10 | init | Mizuho | — → Outperform | $2 |
| 2025-03-05 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-11-15 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-08-14 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2024-03-11 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2023-11-14 | reit | HC Wainwright & Co. | Buy → Buy | $2 |
| 2023-08-15 | main | HC Wainwright & Co. | Buy → Buy | $2 |
| 2023-07-19 | init | Jefferies | — → Underperform | $1 |
| 2023-05-11 | reit | HC Wainwright & Co. | Buy → Buy | $3 |
| 2022-07-25 | main | HC Wainwright & Co. | — → Buy | $3 |
| 2021-08-19 | init | HC Wainwright & Co. | — → Buy | $6 |
| 2021-04-01 | down | SVB Leerink | Outperform → Market Perform | $3 |
| 2021-03-05 | down | Raymond James | Market Perform → Underperform | — |
| 2021-03-05 | main | SVB Leerink | — → Outperform | $3 |
- Why Analysts See Senseonics Holdings (SENS) Story Shifting After Target Cut And Stock Split - Yahoo Finance Mon, 02 Feb 2026 08
- Diabetes implant maker sees 71% sales jump as year-long glucose monitor grows - Stock Titan Mon, 12 Jan 2026 08
- Senseonics: Eversense 365 Is A Game Changer For The CGM Industry (NASDAQ:SENS) - Seeking Alpha Fri, 19 Dec 2025 08
- Senseonics Holdings, Inc. (SENS) Stock Analysis: A 265% Potential Upside Beckons Investors - DirectorsTalk Interviews hu, 23 Oct 2025 07
- Senators’ stock trades directly overlapped with their committee work, CNN analysis finds - CNN Mon, 09 Feb 2026 08
- Exclusive / Senate takes aim, gently, at tech companies’ supervoting stock - Semafor hu, 12 Feb 2026 08
- SENS Stock Up as Eversense 365 Enters AID Market With twiist System - Yahoo Finance Fri, 09 Jan 2026 08
- Sens. Slotkin, Gallego discuss Medicaid, need to share personal stories as part of advocacy efforts - American Hospital Association ue, 06 May 2025 07
- Senseonics Holdings (SENS): Evaluating Valuation After 91% Revenue Growth and Reverse Split Announcement - simplywall.st Wed, 08 Oct 2025 07
- Senseonics posts strong preliminary Q3 sales, reverse stock split - Drug Delivery Business Mon, 06 Oct 2025 07
- Year-long glucose implant now links to insulin pump, easing life with type 1 diabetes - Stock Titan hu, 19 Feb 2026 13
- Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 195% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews hu, 04 Dec 2025 08
- SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval - Yahoo Finance Fri, 30 Jan 2026 08
- $8.1M Q3 2025 Revenue — Senseonics Sees 160% U.S. New Patient Growth; 1:20 Reverse Split Oct 17 - Stock Titan Mon, 06 Oct 2025 07
- Senseonics (SENS) Moves 5.3% Higher: Will This Strength Last? - Yahoo Finance Mon, 02 Feb 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 2398 | 14124.0 | — | Stock Award(Grant) at price 5.89 per share. | FIORENTINO EDWARD J | Director | — | 2026-01-02 00:00:00 | D |
| 1 | 2504 | 14749.0 | — | Stock Award(Grant) at price 5.89 per share. | ROEDER DOUGLAS A | Director | — | 2026-01-02 00:00:00 | D |
| 2 | 1379 | 8122.0 | — | Stock Award(Grant) at price 5.89 per share. | PRINCE DOUGLAS S | Director | — | 2026-01-02 00:00:00 | D |
| 3 | 2185 | 12870.0 | — | Stock Award(Grant) at price 5.89 per share. | STEVEN EDELMAN VICTOR | Director | — | 2026-01-02 00:00:00 | D |
| 4 | 10000 | 65500.0 | — | Purchase at price 6.55 per share. | STEVEN EDELMAN VICTOR | Director | — | 2025-11-10 00:00:00 | D |
| 5 | 15000 | 87450.0 | — | Purchase at price 5.83 per share. | ROEDER DOUGLAS A | Director | — | 2025-11-07 00:00:00 | D |
| 6 | 17210 | 101023.0 | — | Purchase at price 5.87 per share. | GOODNOW TIMOTHY TODD | Chief Executive Officer | — | 2025-11-07 00:00:00 | D |
| 7 | 5415 | 31840.0 | — | Purchase at price 5.88 per share. | SULLIVAN FREDERICK T | Chief Financial Officer | — | 2025-11-07 00:00:00 | D |
| 8 | 34200 | 14125.0 | — | Stock Award(Grant) at price 0.41 per share. | FIORENTINO EDWARD J | Director | — | 2025-10-01 00:00:00 | D |
| 9 | 35714 | 14750.0 | — | Stock Award(Grant) at price 0.41 per share. | ROEDER DOUGLAS A | Director | — | 2025-10-01 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -68.81M | -68.76M | -65.92M | -55.87M |
| TotalUnusualItems | 102.00K | 20.76M | 227.73M | -228.64M |
| TotalUnusualItemsExcludingGoodwill | 102.00K | 20.76M | 227.73M | -228.64M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -78.62M | -60.39M | 142.12M | -302.47M |
| ReconciledDepreciation | 1.48M | 1.28M | 985.00K | 1.24M |
| ReconciledCostOfRevenue | 21.94M | 19.30M | 13.66M | 14.49M |
| EBITDA | -68.70M | -48.01M | 161.81M | -284.51M |
| EBIT | -70.18M | -49.28M | 160.82M | -285.75M |
| NetInterestIncome | -3.94M | -5.75M | -16.88M | -16.48M |
| InterestExpense | 8.44M | 11.11M | 18.70M | 16.72M |
| InterestIncome | 4.50M | 5.36M | 1.82M | 243.00K |
| NormalizedIncome | -78.72M | -81.15M | -85.61M | -73.83M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -78.62M | -60.39M | 142.12M | -302.47M |
| TotalExpenses | 97.31M | 97.99M | 85.02M | 70.86M |
| TotalOperatingIncomeAsReported | -74.84M | -75.60M | -68.63M | -57.18M |
| DilutedAverageShares | 629.72M | 567.97M | 618.21M | 422.32M |
| BasicAverageShares | 629.72M | 567.97M | 467.95M | 422.32M |
| DilutedEPS | -0.12 | -0.11 | -0.11 | -0.72 |
| BasicEPS | -0.12 | -0.11 | 0.30 | -0.72 |
| DilutedNIAvailtoComStockholders | -78.62M | -60.39M | -67.15M | -302.47M |
| AverageDilutionEarnings | 0.00 | -209.27M | 0.00 | |
| NetIncomeCommonStockholders | -78.62M | -60.39M | 142.12M | -302.47M |
| NetIncome | -78.62M | -60.39M | 142.12M | -302.47M |
| NetIncomeIncludingNoncontrollingInterests | -78.62M | -60.39M | 142.12M | -302.47M |
| NetIncomeContinuousOperations | -78.62M | -60.39M | 142.12M | -302.47M |
| PretaxIncome | -78.62M | -60.39M | 142.12M | -302.47M |
| OtherIncomeExpense | 161.00K | 20.96M | 227.62M | -228.81M |
| OtherNonOperatingIncomeExpenses | 59.00K | 202.00K | -102.00K | -173.00K |
| SpecialIncomeCharges | 0.00 | -239.00K | -1.32M | |
| OtherSpecialCharges | 101.00K | -330.00K | ||
| WriteOff | 0.00 | 138.00K | 1.65M | |
| GainOnSaleOfSecurity | 102.00K | 20.76M | 227.97M | -227.32M |
| NetNonOperatingInterestIncomeExpense | -3.94M | -5.75M | -16.88M | -16.48M |
| InterestExpenseNonOperating | 8.44M | 11.11M | 18.70M | 16.72M |
| InterestIncomeNonOperating | 4.50M | 5.36M | 1.82M | 243.00K |
| OperatingIncome | -74.84M | -75.60M | -68.63M | -57.18M |
| OperatingExpense | 75.38M | 78.69M | 71.35M | 56.37M |
| ResearchAndDevelopment | 41.14M | 48.75M | 39.72M | 27.22M |
| SellingGeneralAndAdministration | 34.23M | 29.94M | 31.63M | 29.15M |
| SellingAndMarketingExpense | 7.62M | |||
| GeneralAndAdministrativeExpense | 21.54M | |||
| OtherGandA | 21.54M | |||
| GrossProfit | 533.00K | 3.09M | 2.73M | -811.00K |
| CostOfRevenue | 21.94M | 19.30M | 13.66M | 14.49M |
| TotalRevenue | 22.47M | 22.39M | 16.39M | 13.68M |
| OperatingRevenue | 22.47M | 22.39M | 16.39M | 13.68M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 595.35M | 530.36M | 479.64M | 447.28M |
| ShareIssued | 595.35M | 530.36M | 479.64M | 447.28M |
| NetDebt | 36.17M | 29.26M | ||
| TotalDebt | 61.05M | 47.78M | 75.38M | 63.30M |
| TangibleBookValue | -17.04M | 35.80M | -2.58M | -185.53M |
| InvestedCapital | 38.29M | 76.99M | 69.39M | -122.81M |
| WorkingCapital | 52.59M | 112.77M | 129.73M | 126.02M |
| NetTangibleAssets | -17.04M | 35.80M | -2.58M | -185.53M |
| CapitalLeaseObligations | 6.21M | 6.58M | 3.41M | 579.00K |
| CommonStockEquity | -16.55M | 35.80M | -2.58M | -185.53M |
| TotalCapitalization | 18.15M | 76.99M | 53.81M | -125.74M |
| TotalEquityGrossMinorityInterest | -16.55M | 35.80M | -2.58M | -185.53M |
| StockholdersEquity | -16.55M | 35.80M | -2.58M | -185.53M |
| GainsLossesNotAffectingRetainedEarnings | 0.00 | -11.00K | -678.00K | -212.00K |
| OtherEquityAdjustments | -11.00K | -678.00K | -212.00K | |
| RetainedEarnings | -947.87M | -869.26M | -808.87M | -950.99M |
| AdditionalPaidInCapital | 930.72M | 904.53M | 806.49M | 765.22M |
| CapitalStock | 595.00K | 530.00K | 480.00K | 447.00K |
| CommonStock | 595.00K | 530.00K | 480.00K | 447.00K |
| TotalLiabilitiesNetMinorityInterest | 116.99M | 102.42M | 180.25M | 384.46M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 78.14M | 85.17M | 148.78M | 366.07M |
| OtherNonCurrentLiabilities | 2.69M | 579.00K | ||
| PreferredSecuritiesOutsideStockEquity | 37.66M | 37.66M | 37.66M | 0.00 |
| DerivativeProductLiabilities | 0.00 | 102.00K | 52.05M | 305.69M |
| LongTermDebtAndCapitalLeaseObligation | 40.49M | 47.41M | 59.07M | 60.38M |
| LongTermCapitalLeaseObligation | 5.79M | 6.21M | 2.69M | 579.00K |
| LongTermDebt | 34.70M | 41.20M | 56.38M | 59.80M |
| CurrentLiabilities | 38.85M | 17.26M | 31.47M | 18.39M |
| OtherCurrentLiabilities | 71.00K | 27.00K | 34.00K | 3.00K |
| CurrentDebtAndCapitalLeaseObligation | 20.57M | 368.00K | 16.30M | 2.93M |
| CurrentCapitalLeaseObligation | 429.00K | 368.00K | 725.00K | 904.00K |
| CurrentDebt | 20.14M | 15.58M | 2.93M | |
| OtherCurrentBorrowings | 15.58M | 2.93M | ||
| CurrentNotesPayable | 20.14M | 0.00 | 15.58M | 0.00 |
| PensionandOtherPostRetirementBenefitPlansCurrent | 5.31M | 4.80M | 4.70M | 3.48M |
| CurrentProvisions | 406.00K | 514.00K | 781.00K | 1.70M |
| PayablesAndAccruedExpenses | 12.49M | 11.55M | 9.65M | 15.47M |
| CurrentAccruedExpenses | 9.29M | 6.98M | 9.23M | 14.26M |
| InterestPayable | 789.00K | 704.00K | 2.05M | 2.14M |
| Payables | 3.21M | 4.57M | 419.00K | 1.20M |
| AccountsPayable | 3.21M | 4.57M | 419.00K | 1.20M |
| TotalAssets | 100.44M | 138.22M | 177.67M | 198.93M |
| TotalNonCurrentAssets | 9.00M | 8.19M | 16.47M | 54.52M |
| OtherNonCurrentAssets | 4.93M | 7.01M | 3.11M | 1.09M |
| NonCurrentPrepaidAssets | 3.11M | 1.09M | ||
| FinancialAssets | 0.00 | 239.00K | ||
| InvestmentsAndAdvances | 0.00 | 12.25M | 51.88M | |
| GoodwillAndOtherIntangibleAssets | 481.92K | 0.00 | ||
| OtherIntangibleAssets | 481.92K | |||
| NetPPE | 3.59M | 1.18M | 1.11M | 1.31M |
| AccumulatedDepreciation | -2.37M | -2.48M | -2.04M | -1.53M |
| GrossPPE | 5.96M | 3.67M | 3.15M | 2.84M |
| Leases | 2.20M | 530.00K | 128.00K | 127.00K |
| OtherProperties | 2.67M | 2.36M | ||
| MachineryFurnitureEquipment | 3.76M | 3.14M | 3.02M | 2.71M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 91.44M | 130.03M | 161.20M | 144.41M |
| OtherCurrentAssets | 18.00K | 1.00K | 12.00K | 56.00K |
| RestrictedCash | 315.00K | 0.00 | 0.00 | |
| PrepaidAssets | 4.01M | 5.20M | 7.08M | 5.72M |
| Inventory | 4.42M | 8.78M | 7.31M | 6.32M |
| FinishedGoods | 781.00K | 2.16M | 1.70M | 1.01M |
| WorkInProcess | 3.21M | 5.33M | 4.06M | 3.77M |
| RawMaterials | 427.00K | 1.28M | 1.55M | 1.53M |
| Receivables | 8.08M | 6.60M | 2.79M | 2.42M |
| DuefromRelatedPartiesCurrent | 2.32M | 1.77M | ||
| TaxesReceivable | 1.79M | 1.79M | 0.00 | |
| AccruedInterestReceivable | 0.00 | 272.00K | 336.00K | 443.00K |
| AccountsReceivable | 6.29M | 4.53M | 2.45M | 1.97M |
| GrossAccountsReceivable | 6.29M | 4.53M | 2.45M | 1.97M |
| CashCashEquivalentsAndShortTermInvestments | 74.60M | 109.46M | 144.01M | 129.91M |
| OtherShortTermInvestments | 0.00 | 33.75M | 108.22M | 96.44M |
| CashAndCashEquivalents | 74.60M | 75.71M | 35.79M | 33.46M |
| CashEquivalents | 70.61M | 72.95M | 34.66M | 29.20M |
| CashFinancial | 3.98M | 2.76M | 1.14M | 4.26M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -62.70M | -70.51M | -66.62M | -56.29M |
| RepaymentOfDebt | 0.00 | -23.20M | -2.93M | -2.84M |
| IssuanceOfDebt | 9.95M | 24.45M | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 18.36M | 7.38M | 46.17M | 223.15M |
| CapitalExpenditure | -2.24M | -350.00K | -312.00K | -210.00K |
| InterestPaidSupplementalData | 4.51M | 3.68M | 6.57M | 7.82M |
| EndCashPosition | 74.91M | 75.71M | 35.79M | 33.46M |
| BeginningCashPosition | 75.71M | 35.79M | 33.46M | 18.20M |
| ChangesInCash | -797.00K | 39.92M | 2.33M | 15.26M |
| FinancingCashFlow | 26.83M | 20.37M | 41.76M | 220.08M |
| CashFlowFromContinuingFinancingActivities | 26.83M | 20.37M | 41.76M | 220.08M |
| NetOtherFinancingCharges | -1.66M | -3.03M | -2.57M | -5.29M |
| ProceedsFromStockOptionExercised | 179.00K | 14.77M | 1.08M | 5.07M |
| NetPreferredStockIssuance | 0.00 | 12.00M | 22.78M | |
| PreferredStockIssuance | 0.00 | 12.00M | 22.78M | |
| NetCommonStockIssuance | 18.36M | 7.38M | 34.17M | 200.37M |
| CommonStockIssuance | 18.36M | 7.38M | 34.17M | 200.37M |
| NetIssuancePaymentsOfDebt | 9.95M | 1.25M | -2.93M | -2.84M |
| NetLongTermDebtIssuance | 9.95M | 1.25M | -2.93M | -2.84M |
| LongTermDebtPayments | 0.00 | -23.20M | -2.93M | -2.84M |
| LongTermDebtIssuance | 9.95M | 24.45M | 0.00 | 0.00 |
| InvestingCashFlow | 32.84M | 89.71M | 26.88M | -148.75M |
| CashFlowFromContinuingInvestingActivities | 32.84M | 89.71M | 26.88M | -148.75M |
| NetInvestmentPurchaseAndSale | 35.08M | 90.06M | 27.19M | -148.54M |
| SaleOfInvestment | 93.09M | 158.60M | 131.90M | 5.97M |
| PurchaseOfInvestment | -58.02M | -68.54M | -104.71M | -154.51M |
| CapitalExpenditureReported | -2.24M | -350.00K | -312.00K | -210.00K |
| OperatingCashFlow | -60.47M | -70.16M | -66.31M | -56.08M |
| CashFlowFromContinuingOperatingActivities | -60.47M | -70.16M | -66.31M | -56.08M |
| ChangeInWorkingCapital | 865.00K | -3.97M | -2.47M | -1.50M |
| ChangeInOtherCurrentLiabilities | -912.00K | -1.12M | -757.00K | -904.00K |
| ChangeInPayablesAndAccruedExpense | 879.00K | 1.27M | 582.00K | 2.03M |
| ChangeInAccruedExpense | 2.71M | -1.03M | 1.37M | 2.59M |
| ChangeInInterestPayable | 86.00K | 31.00K | -95.00K | 372.00K |
| ChangeInPayable | -1.83M | 2.30M | -785.00K | -559.00K |
| ChangeInAccountPayable | -1.83M | 2.30M | -785.00K | -559.00K |
| ChangeInPrepaidAssets | 2.90M | -276.00K | -829.00K | -2.61M |
| ChangeInInventory | 696.00K | -1.64M | -989.00K | -1.04M |
| ChangeInReceivables | -2.70M | -2.19M | -478.00K | 1.01M |
| ChangesInAccountReceivables | -2.70M | -2.19M | -478.00K | 1.01M |
| OtherNonCashItems | 4.07M | 7.49M | 12.16M | 8.46M |
| StockBasedCompensation | 9.22M | 8.67M | 8.62M | 9.03M |
| ProvisionandWriteOffofAssets | 3.94M | 174.00K | 0.00 | |
| AssetImpairmentCharge | 0.00 | 138.00K | 2.17M | |
| AmortizationOfSecurities | -1.32M | -2.67M | ||
| DepreciationAmortizationDepletion | 1.48M | 1.28M | 985.00K | 1.24M |
| DepreciationAndAmortization | 1.48M | 1.28M | 985.00K | 1.24M |
| Depreciation | 1.48M | 1.28M | 985.00K | 1.24M |
| OperatingGainsLosses | -102.00K | -20.75M | -227.87M | 227.00M |
| GainLossOnInvestmentSecurities | -102.00K | -6.65M | -227.87M | 227.00M |
| NetForeignCurrencyExchangeGainLoss | 0.00 | -14.11M | 0.00 | |
| NetIncomeFromContinuingOperations | -78.62M | -60.39M | 142.12M | -302.47M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for SENS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|